Infectious disease Archives

News and Trends 19 Jul 2022

Good news for Destiny Pharma’s nasal gel to combat life-threatening infections

Clinical stage biotech company, Destiny Pharma, announced today (July 19) a positive update from the U.S. Food and Drug Administration (FDA) on its XF-73 nasal gel phase 3 development plans. The FDA has clarified the phase 3 and U.S. registration pathway for the gel for the prevention of post-surgical staphylococcal infections, and this feedback enables […]

July 19, 2022 - 5 minutesmins - By Liza Laws

News and Trends 12 Jul 2022

Spanish company, 3P Biopharmaceuticals, manufactures biomass to treat black fungus

A biomass to treat a difficult and evasive fungal infection with a high mortality rate has been manufactured by Spanish organization, 3P Biopharmaceuticals (3P). It created BSG005 biomass for its partner and client, Biosergen, a Norwegian biotechnology company that has just announced a phase 2 clinical trial of the product against mucormycosis – also known […]

July 12, 2022 - 3 minutesmins - By Liza Laws

News and Trends 22 Jun 2022

Millions invested for progression of Lyme disease vaccine

Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. A deal has been struck with Valneva SE that will see the start of the phase 3 study of the disease’s vaccine candidate, VLA15. This is scheduled for the third quarter of this year. The investment will represent 8.1% of […]

June 22, 2022 - 2 minutesmins - By Liza Laws

News and Trends 8 Jun 2022

Synklino raises €29.8M to trial cytomegalovirus drug

Danish biotech Synklino has completed a Series A fundraising round that netted €29.8M ($31.8M). The company is developing drugs for the treatment of chronic viral infections, and the funding will be used for its drug candidate, SYN002, for the treatment of cytomegalovirus (CMV). This will involve both ex vivo and in vivo Phase 1 clinical […]

June 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 24 May 2022

Vaccines mobilized to control monkeypox outbreak

An unusual outbreak of monkeypox is causing concern worldwide in the shadow of the destructive Covid-19 pandemic. Both old and emerging vaccine technology could aid the fight against the outbreak. In the wake of the world-changing Covid-19 pandemic, the World Health Organization (WHO) is voicing alarm over another unusual outbreak, this time of the viral […]

May 24, 2022 - 5 minutesmins - By Jonathan Smith

stephanie bewick destiny pharma chief business officer

Expert Advice 2 May 2022

Chief Business Officers: Shedding Light on Biotech’s Dealmakers

In addition to helping patients, biotech companies need to focus on the commercial potential of their work. Stephanie Bewick at Destiny Pharma outlines her experiences of how a Chief Business Officer maximizes their company’s commercial appeal and lands deals in the biotech industry. Stephanie Bewick began her career as an academic researcher before spending more […]

May 2, 2022 - 5 minutesmins - By Victor Kotsev

world health organization genomics pathogen pandemic

News and Trends 5 Apr 2022

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

The World Health Organization has released a 10-year plan to monitor the genetic make-up of pathogens across the globe. The strategy highlights how far genomics has come during the Covid-19 pandemic and how far there is to go. The past two years have seen unprecedented global collaboration as researchers raced to better understand the epidemiology, […]

April 5, 2022 - 4 minutesmins - By Anita Chakraverty

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to healthcare systems worldwide. Numerous treatments and vaccines are hitting the late-stage pipeline, which could greatly expand the anti-Covid-19 arsenal. Two years ago, the Covid-19 pandemic swept the world and left economic disruption, healthcare crises, and widespread lockdowns in its wake. […]

February 15, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 10 Feb 2022

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

An international academic team has made strides in carrying out genome sequencing faster and more cheaply in low- and middle- income nations. This could improve the control of potentially lethal salmonella infections and propel research into vaccines. As the price of DNA sequencing continues to fall, genomics and bioinformatics firms are drawing ever more attention […]

February 10, 2022 - 6 minutesmins - By Jonathan Smith

January Financial Top European Investments

News and Trends 3 Feb 2022

The Top European Biotech Investments in January 2022

Viral infection treatments, cell therapy, and artificial intelligence led biotech investments in January 2022 as the European sector took a collective breather from December’s funding frenzy. European biotech investments started 2022 at a modest level compared to the huge cash flow seen in November and December 2021. While December 2021 saw almost €1.6B money raised, […]

February 3, 2022 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M Series B round, the German firm Ethris is riding the mRNA buzz by developing inhalable mRNA therapies for respiratory diseases. As Covid-19 mRNA vaccines entered the market for the first time in 2020, the wide potential of mRNA technology became […]

February 1, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Jan 2022

French Project to Tackle Antibiotic Resistance with Biotech and Economics

A team of French organizations led by the biotech firm Antabio has launched a €17M project to deploy therapeutic, diagnostic, and economic innovations in the battle against antibiotic resistance. The project, dubbed ARPEGE, involves four partners covering a variety of disciplines: the antibiotics developer Antabio; the diagnostics heavyweight bioMérieux; the university hospital group Hospices Civils […]

January 7, 2022 - 4 minutesmins - By Jonathan Smith

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us